The Covid Moonshot effort to develop antivirals began in 2020 with a tweet. Three and a half years later, the team has a leading drug candidate. This article first appeared in The Checkup, MIT ...

Artificial intelligence spurs more efficient clinical trials by protecting patient privacy and easing regulatory burdens. In association withEgnyte Calithera Biosciences is a small, Northern ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

In this article, we will delve into how technology has impacted the drug industry, from drug trafficking to advancements in the pharmaceutical industry… Technology has been a game-changer in various ...

Researchers have determined that a protein prediction technology can yield accurate results in the hunt to efficiently find the best possible drug candidates for many conditions. Artificial ...

The successful introduction of genetically engineered human and chimeric immunoglobulin proteins has established monoclonal antibodies (mAbs) as a validated approach for treating malignancies. The ...

A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...

While pharmaceutical regulatory authorities in other countries are employing creative ways like video-based remote inspections to fulfill their obligations to the public, the U.S. Food and Drug ...

The pharmaceutical industry is entering an inflection point driven by the recognition that highly potent cancer drugs are only as effective as their ability to reach tumors with sufficient ...

Shares of Midatech Pharma soar after the company announces a ‘breakthrough’ in the development of its injectable drug-therapy delivery technology. Midatech Pharma (MTP) shares soared Thursday after ...

The approval marks the first new pharmacologic treatment in motion sickness in over four decades. The US Food and Drug ...